Trial · NCT00348881
Adverse events56
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 56
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Solicited injection site Pain | General disorders | Group 1: DTaP-Hep B-PRP~T + OPV | 958 | 1,425 | |
| other | Solicited injection site Pain | General disorders | Group 2: Tritanrix-Hep B/ Hib™ + OPV | 573 | 708 | |
| other | Solicited injection site Erythema | General disorders | Group 1: DTaP-Hep B-PRP~T + OPV | 543 | 1,425 | |
| other | Solicited injection site Erythema | General disorders | Group 2: Tritanrix-Hep B/ Hib™ + OPV | 353 | 708 | |
| other | Solicited injection site Swelling | General disorders | Group 1: DTaP-Hep B-PRP~T + OPV | 576 | 1,425 | |
| other | Solicited injection site Swelling | General disorders | Group 2: Tritanrix-Hep B/ Hib™ + OPV | 423 | 708 | |
| other | Pyrexia | General disorders | Group 1: DTaP-Hep B-PRP~T + OPV | 282 | 1,425 | |
| other | Pyrexia | General disorders | Group 2: Tritanrix-Hep B/ Hib™ + OPV | 248 | 708 | |
| other | Vomiting | Gastrointestinal disorders | Group 1: DTaP-Hep B-PRP~T + OPV | 193 | 1,425 | |
| other | Vomiting | Gastrointestinal disorders | Group 2: Tritanrix-Hep B/ Hib™ + OPV | 118 | 708 | |
| other | Crying | Psychiatric disorders | Group 1: DTaP-Hep B-PRP~T + OPV | 431 | 1,425 | |
| other | Crying | Psychiatric disorders | Group 2: Tritanrix-Hep B/ Hib™ + OPV | 301 | 708 | |
| other | Anorexia | Metabolism and nutrition disorders | Group 1: DTaP-Hep B-PRP~T + OPV | 235 | 1,425 | |
| other | Anorexia | Metabolism and nutrition disorders | Group 2: Tritanrix-Hep B/ Hib™ + OPV | 159 | 708 | |
| other | Somnolence | Nervous system disorders | Group 1: DTaP-Hep B-PRP~T + OPV | 527 | 1,425 | |
| other | Somnolence | Nervous system disorders | Group 2: Tritanrix-Hep B/ Hib™ + OPV | 282 | 708 | |
| other | Upper respiratory tract infection | Infections and infestations | Group 1: DTaP-Hep B-PRP~T + OPV | 481 | 1,425 | |
| other | Upper respiratory tract infection | Infections and infestations | Group 2: Tritanrix-Hep B/ Hib™ + OPV | 210 | 708 | |
| other | Irritability | Psychiatric disorders | Group 1: DTaP-Hep B-PRP~T + OPV | 823 | 1,425 | |
| other | Irritability | Psychiatric disorders | Group 2: Tritanrix-Hep B/ Hib™ + OPV | 471 | 708 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00348881/events